1
00:00:02,720 --> 00:00:10,600
Speaker 1: Bloomberg Audio Studios, Podcasts, radio news. You're listening to the

2
00:00:10,600 --> 00:00:14,600
Speaker 1: Bloomberg Intelligence Podcast. Catch us live weekdays at ten am

3
00:00:14,640 --> 00:00:18,560
Speaker 1: Eastern on Applecarclay, and Android Auto with the Bloomberg Business App.

4
00:00:18,640 --> 00:00:21,920
Speaker 1: Listen on demand wherever you get your podcasts, or watch

5
00:00:21,960 --> 00:00:23,120
Speaker 1: us live on YouTube.

6
00:00:23,760 --> 00:00:25,520
Speaker 2: Eli Lilly, it.

7
00:00:25,560 --> 00:00:28,240
Speaker 3: Had a salespaper. Shares are taken ahead, Yeah, Lily shares

8
00:00:28,240 --> 00:00:31,720
Speaker 3: it down about fourteen percent. There is something overshadowing that.

9
00:00:31,840 --> 00:00:33,919
Speaker 3: For that, we're going to bring in Damien Gardett's Bloomberg

10
00:00:33,960 --> 00:00:36,960
Speaker 3: News health reporter. Damian, thanks for joining us here in

11
00:00:37,000 --> 00:00:41,199
Speaker 3: the studio. So it looks like this experiment, this drug experiment,

12
00:00:41,240 --> 00:00:43,600
Speaker 3: the weight loss pill, and that's the thing here. It

13
00:00:43,640 --> 00:00:46,640
Speaker 3: didn't do as well in the study as Wall Street had.

14
00:00:46,560 --> 00:00:50,120
Speaker 4: Expected exactly so it met its goals and it helped

15
00:00:50,120 --> 00:00:51,680
Speaker 4: people lose weight, which was the whole point of it.

16
00:00:51,680 --> 00:00:54,960
Speaker 4: This was enrolling people with obesity, but that weight loss

17
00:00:55,000 --> 00:00:58,520
Speaker 4: was about eleven percent of body weight, and Wall Street

18
00:00:58,560 --> 00:01:01,040
Speaker 4: was hoping to see something more kin to fourteen to

19
00:01:01,080 --> 00:01:04,720
Speaker 4: fifteen percent, which would match what's seen with the injectible

20
00:01:05,000 --> 00:01:07,960
Speaker 4: GLP one weight loss medicines like with GOVI from rival

21
00:01:08,000 --> 00:01:11,320
Speaker 4: Novo Nordisk. So despite the trial being a success, and

22
00:01:11,360 --> 00:01:14,360
Speaker 4: despite this pill seemingly on the path to winning FDA

23
00:01:14,400 --> 00:01:16,800
Speaker 4: approval and hitting the market as early as next year,

24
00:01:17,240 --> 00:01:22,600
Speaker 4: the reaction, as you mentioned, was dramatically negative formulaly because these,

25
00:01:22,680 --> 00:01:25,640
Speaker 4: you know, single digit percentage differences are perceived to be

26
00:01:25,959 --> 00:01:29,479
Speaker 4: massively important to the ultimate financial future. It's medicine.

27
00:01:29,720 --> 00:01:32,399
Speaker 5: Here's the thing for me knowing someone that does this

28
00:01:32,480 --> 00:01:37,319
Speaker 5: GLP one thing, whatever it is. You gotta reduce the

29
00:01:37,319 --> 00:01:40,200
Speaker 5: side effects of the nausea, and this one didn't. And

30
00:01:40,240 --> 00:01:43,319
Speaker 5: that was the I know people that use it and

31
00:01:43,400 --> 00:01:45,720
Speaker 5: use the injection or saying, boy, when the oral one

32
00:01:45,760 --> 00:01:49,160
Speaker 5: comes out, I'm told that the side effects will be

33
00:01:49,400 --> 00:01:52,720
Speaker 5: dramatically less, which is a huge selling point, and I

34
00:01:52,720 --> 00:01:54,040
Speaker 5: guess that's not what they saw here.

35
00:01:54,120 --> 00:01:57,680
Speaker 4: Basically, in this study, they saw gastro intestinal side effects

36
00:01:57,680 --> 00:02:00,280
Speaker 4: that were comparable to the injectible one, which your point

37
00:02:00,400 --> 00:02:02,360
Speaker 4: could be viewed as a negative. There was a I

38
00:02:02,400 --> 00:02:05,120
Speaker 4: think there was a home run scenario where Lily's pill

39
00:02:05,160 --> 00:02:07,680
Speaker 4: would both lead to a greater percentage of body weight

40
00:02:07,760 --> 00:02:11,200
Speaker 4: loss and as you mentioned, have fewer of the nausea

41
00:02:11,720 --> 00:02:12,520
Speaker 4: vomiting field.

42
00:02:12,560 --> 00:02:15,760
Speaker 5: Plus that were we being the pharmaceutical biotech, and we're

43
00:02:15,760 --> 00:02:20,000
Speaker 5: in the early innings of this GLP type obesity thing.

44
00:02:20,760 --> 00:02:22,320
Speaker 5: I can't imagine why it's not going to get better

45
00:02:22,360 --> 00:02:24,880
Speaker 5: and better and better and better, or I don't know

46
00:02:24,880 --> 00:02:27,000
Speaker 5: the science. Maybe we're already at that limit. We are

47
00:02:27,080 --> 00:02:29,480
Speaker 5: at the limit of this whatever this thing is.

48
00:02:29,639 --> 00:02:31,239
Speaker 4: I don't think so. I mean, in granted, you know

49
00:02:31,280 --> 00:02:34,680
Speaker 4: clinical trials need to play out. Science biology famously unpredictable,

50
00:02:34,880 --> 00:02:37,240
Speaker 4: but I would say the space is moving in two directions.

51
00:02:37,280 --> 00:02:40,480
Speaker 4: One combination medicines that add GLP one to other things

52
00:02:40,480 --> 00:02:42,560
Speaker 4: that can lead to more dramatic weight loss, and then

53
00:02:42,639 --> 00:02:45,600
Speaker 4: two more convenient things like pills that you can take

54
00:02:45,639 --> 00:02:48,120
Speaker 4: that maybe don't have the same effect on body weight,

55
00:02:48,200 --> 00:02:50,680
Speaker 4: but that would be cheaper to manufacture, presumably cheaper to

56
00:02:50,800 --> 00:02:54,040
Speaker 4: acquire for patients because these injectables have list prices of

57
00:02:54,120 --> 00:02:57,200
Speaker 4: inexcess of one thousand dollars a month. So in the

58
00:02:57,240 --> 00:02:59,560
Speaker 4: best case scenario, let's say five years from now, there

59
00:02:59,560 --> 00:03:02,880
Speaker 4: will be an armamentarium of weight loss medicines. If you

60
00:03:03,240 --> 00:03:05,799
Speaker 4: an armamentarium, which I think I stumbled over a whole

61
00:03:05,800 --> 00:03:08,440
Speaker 4: bunch of them, like in an armory. Let's say so

62
00:03:08,480 --> 00:03:11,440
Speaker 4: a physician yes, a physician, could you know, diagnose a

63
00:03:11,480 --> 00:03:14,080
Speaker 4: patient and say, for some people you will need an

64
00:03:14,080 --> 00:03:16,240
Speaker 4: injectable that you can lose twenty five percent of your

65
00:03:16,240 --> 00:03:18,359
Speaker 4: body weight on. For some people you may be good

66
00:03:18,360 --> 00:03:20,840
Speaker 4: with an oral medicine where you lose a single digit

67
00:03:20,960 --> 00:03:23,280
Speaker 4: or even ten percent of your body weight, or mixing

68
00:03:23,360 --> 00:03:26,680
Speaker 4: and matching using one for maintenance and the upside being

69
00:03:26,960 --> 00:03:29,919
Speaker 4: theoretically this will one become a massive one hundred billion

70
00:03:29,960 --> 00:03:32,760
Speaker 4: dollar market for the pharmaceutical industry, but two have knock

71
00:03:32,800 --> 00:03:34,480
Speaker 4: on beneficial effects for people's health.

72
00:03:34,680 --> 00:03:36,560
Speaker 3: So where do we stand with the pills? I mean,

73
00:03:36,600 --> 00:03:39,360
Speaker 3: what other competition is out there? Who else is working

74
00:03:39,400 --> 00:03:40,960
Speaker 3: on one that we should keep an eye on as well.

75
00:03:41,200 --> 00:03:44,680
Speaker 4: So Novo Nordisk has an oral version of the injectable

76
00:03:44,720 --> 00:03:49,040
Speaker 4: week govy. It is not as convenient or I would

77
00:03:49,040 --> 00:03:51,920
Speaker 4: say innovative frankly, as Lily's pill, because it's basically just

78
00:03:52,040 --> 00:03:55,080
Speaker 4: a bunch of wgovy shoved into a tablet that you

79
00:03:55,160 --> 00:03:57,880
Speaker 4: eat and it sits in your gut and administers the

80
00:03:57,920 --> 00:04:00,520
Speaker 4: drug there. And that it comes with restriction. You can't

81
00:04:00,520 --> 00:04:01,680
Speaker 4: take it with food, you have to do it in

82
00:04:01,680 --> 00:04:04,800
Speaker 4: the morning. It's not really as attractive a commercial product,

83
00:04:04,840 --> 00:04:07,000
Speaker 4: I think it's fair to say as Lilies, but there

84
00:04:07,000 --> 00:04:11,440
Speaker 4: are other oral options from smaller biotech companies that we

85
00:04:11,560 --> 00:04:14,080
Speaker 4: may see them progress to the market. There's also a

86
00:04:14,120 --> 00:04:16,479
Speaker 4: lot of m and a speculation around these firms that

87
00:04:16,520 --> 00:04:19,440
Speaker 4: a company like Pfizer, for example, which kind of crashed

88
00:04:19,440 --> 00:04:21,159
Speaker 4: and burned with its first attempt to make a GLP

89
00:04:21,240 --> 00:04:24,160
Speaker 4: one pill, might acquire them. So this is very much

90
00:04:24,200 --> 00:04:26,040
Speaker 4: a space to watch. I would say a year from now,

91
00:04:26,080 --> 00:04:28,880
Speaker 4: it's quite likely that it will look demonstrably different than

92
00:04:28,920 --> 00:04:29,640
Speaker 4: it looks right now.

93
00:04:29,760 --> 00:04:32,480
Speaker 5: So as I look at the PGeo table, which kind

94
00:04:32,480 --> 00:04:36,320
Speaker 5: of breaks down where the revenue comes from Lily, where

95
00:04:36,480 --> 00:04:39,679
Speaker 5: is the cardio metabolic health is at the sector again,

96
00:04:39,760 --> 00:04:43,159
Speaker 5: now that's that sector is sixty five percent of total revenue.

97
00:04:43,400 --> 00:04:46,120
Speaker 5: So that's a big deal for Lily.

98
00:04:45,960 --> 00:04:48,200
Speaker 4: And that's not inclusive of this oral drug which isn't

99
00:04:48,200 --> 00:04:50,400
Speaker 4: even approved yet. So I mean, as you mentioned these

100
00:04:50,480 --> 00:04:53,719
Speaker 4: data overshadowing, Lily had like a blowout quarter. They're approved

101
00:04:53,760 --> 00:04:57,320
Speaker 4: medicine for obesity and the same thing is sold for diabetes.

102
00:04:57,320 --> 00:05:00,080
Speaker 4: Both of them beat estimates, they raised revenue guide and

103
00:05:00,400 --> 00:05:03,520
Speaker 4: profit guidance. They're doing very very well, but I think

104
00:05:03,720 --> 00:05:05,680
Speaker 4: the stock reaction today is sort of an illustration of

105
00:05:05,720 --> 00:05:08,960
Speaker 4: just how much is baked into the potential of these medicines.

106
00:05:09,000 --> 00:05:12,320
Speaker 4: Lily has flirted with being a trillion dollar valuation company.

107
00:05:12,320 --> 00:05:15,560
Speaker 4: They're not there anymore, but that's strictly a reflection of

108
00:05:15,600 --> 00:05:18,320
Speaker 4: what people believe will come of this class of medicine.

109
00:05:18,360 --> 00:05:20,360
Speaker 3: So, speaking of the potential, then, so why is the

110
00:05:20,400 --> 00:05:23,600
Speaker 3: science behind these pills? Why is it such a challenge.

111
00:05:24,480 --> 00:05:28,719
Speaker 4: I mean, getting what you can do in an injectable medicine,

112
00:05:28,760 --> 00:05:31,720
Speaker 4: getting that down into a pill has been deviled the

113
00:05:31,760 --> 00:05:35,360
Speaker 4: drug industry for many, many years because there are safety concerns,

114
00:05:35,400 --> 00:05:38,760
Speaker 4: there are dosing concerns. The ideal product is like a

115
00:05:38,760 --> 00:05:41,680
Speaker 4: superpill that prolongs your life and et cetera. But there's

116
00:05:41,720 --> 00:05:44,320
Speaker 4: a reason we have so few of those, and it's

117
00:05:44,360 --> 00:05:47,599
Speaker 4: basically just the trial and error and the unpredictability of biology.

118
00:05:48,240 --> 00:05:50,159
Speaker 4: And I think these companies are always trying to bend

119
00:05:50,160 --> 00:05:52,200
Speaker 4: the curves of failures. But like it remains true that

120
00:05:52,279 --> 00:05:55,279
Speaker 4: roughly one in ten medicines actually makes it from the

121
00:05:55,400 --> 00:05:57,599
Speaker 4: lab to the pharmacy.

122
00:05:57,720 --> 00:06:03,120
Speaker 5: My freshman year college chemistry lab partner went on to

123
00:06:03,160 --> 00:06:08,080
Speaker 5: become like this crazy smart dude played a wide receiver

124
00:06:08,120 --> 00:06:13,200
Speaker 5: in the NFL. Then he became a signist an astronaut

125
00:06:13,720 --> 00:06:16,960
Speaker 5: space shuttle crazy and I was like, I was like, dude,

126
00:06:17,000 --> 00:06:19,440
Speaker 5: can you carry me in this chemistry classic because I'm

127
00:06:19,440 --> 00:06:22,039
Speaker 5: not really into it? And he was super smart. So

128
00:06:23,080 --> 00:06:24,839
Speaker 5: and then that he didn't peak there, he didn't He

129
00:06:24,839 --> 00:06:26,599
Speaker 5: didn't peak in the NFL. I guess he peaked the

130
00:06:26,800 --> 00:06:27,760
Speaker 5: flying around in space.

131
00:06:27,960 --> 00:06:28,360
Speaker 1: So good.

132
00:06:28,360 --> 00:06:31,080
Speaker 5: There. What's the next thing that you're looking for in

133
00:06:31,080 --> 00:06:33,880
Speaker 5: a pharmer's space here? What's the next big mover here

134
00:06:34,000 --> 00:06:35,880
Speaker 5: on a company level that you're looking.

135
00:06:35,680 --> 00:06:39,440
Speaker 4: At for weight loss specifically or just more broadly.

136
00:06:39,600 --> 00:06:41,000
Speaker 5: Yeah, I think everything.

137
00:06:41,040 --> 00:06:44,200
Speaker 4: Actually MRK is working on. Speaking of pills, they're working

138
00:06:44,200 --> 00:06:47,599
Speaker 4: on a pill version that would be basically a superstat

139
00:06:47,720 --> 00:06:51,840
Speaker 4: It would lower bad cholesterol to a level that cannot

140
00:06:51,880 --> 00:06:54,960
Speaker 4: be done with oral medicines that exists right now, and

141
00:06:55,000 --> 00:06:58,000
Speaker 4: that it kind of follows this same trajectory that I

142
00:06:58,000 --> 00:07:01,680
Speaker 4: think we're seeing big pharma company years ago after statinshe

143
00:07:01,760 --> 00:07:04,640
Speaker 4: generic kind of moved away from primary care medicines because

144
00:07:04,640 --> 00:07:06,640
Speaker 4: it's difficult, you have to run big trials, it's expensive.

145
00:07:06,680 --> 00:07:08,680
Speaker 4: If they fail, you lose a lot of money. And

146
00:07:08,760 --> 00:07:11,280
Speaker 4: move toward oncology and rare diseases. I feel like we're

147
00:07:11,320 --> 00:07:13,240
Speaker 4: seeing and I think GLP one was sort of the

148
00:07:13,360 --> 00:07:15,800
Speaker 4: trojan horse in some ways of this. We're seeing the

149
00:07:15,800 --> 00:07:18,160
Speaker 4: major drug companies move back toward primary care, trying to

150
00:07:18,200 --> 00:07:20,520
Speaker 4: invent medicines that would be taken by millions of people

151
00:07:20,560 --> 00:07:22,640
Speaker 4: and they would actually address the number one killer of Americans,

152
00:07:22,640 --> 00:07:24,720
Speaker 4: which is heart disease. So I think that's a trend

153
00:07:24,720 --> 00:07:26,800
Speaker 4: that I'm following, and we'll get data from that murk pill,

154
00:07:26,840 --> 00:07:27,960
Speaker 4: I believe by the end of the year.

155
00:07:28,040 --> 00:07:30,240
Speaker 5: All Right, I mean you and Sam Fizzelli, you guys,

156
00:07:30,280 --> 00:07:31,880
Speaker 5: do whatever you do in that healthcare thing. Just tell

157
00:07:31,960 --> 00:07:34,800
Speaker 5: us when something important is happening. Damien Gardelli, a healthcare

158
00:07:34,840 --> 00:07:36,920
Speaker 5: reporter for Bloomberg News, joinings life here in our Bloomberg

159
00:07:36,960 --> 00:07:39,880
Speaker 5: Interactive Broker studio. You know, back in my trading days, man,

160
00:07:40,120 --> 00:07:43,200
Speaker 5: I'd go to my healthcare guy, I say, hey, can

161
00:07:43,240 --> 00:07:46,160
Speaker 5: I buy Lily today? It's down fifteen percent. I mean,

162
00:07:46,880 --> 00:07:49,760
Speaker 5: it feels like an entry point to me, and hopefully

163
00:07:49,760 --> 00:07:51,760
Speaker 5: Mianas will have a good idea what's going on space.

164
00:07:51,800 --> 00:07:53,400
Speaker 3: I mean, you hear the GLP ones are supposed to

165
00:07:53,520 --> 00:07:55,800
Speaker 3: lower cholesterol, but then you have other He was just

166
00:07:55,800 --> 00:07:57,800
Speaker 3: talking about another cholesterol, yes, and coming out.

167
00:07:57,840 --> 00:08:01,360
Speaker 5: But I mean these GLP things have been I see

168
00:08:01,400 --> 00:08:03,120
Speaker 5: a new story every day. How they help this, they

169
00:08:03,280 --> 00:08:05,600
Speaker 5: cure this, they lowered the risk of this. It's not

170
00:08:05,720 --> 00:08:09,240
Speaker 5: just so I don't know what's going. Healthcare space is

171
00:08:09,280 --> 00:08:12,960
Speaker 5: a tough, tough one to invest in. I think that's

172
00:08:12,960 --> 00:08:16,360
Speaker 5: why there's mds and PhDs all over the place in

173
00:08:17,120 --> 00:08:18,840
Speaker 5: investment firms investing in that space.

174
00:08:20,600 --> 00:08:24,280
Speaker 1: You're listening to the Bloomberg Intelligence Podcast. Catch us live

175
00:08:24,360 --> 00:08:27,760
Speaker 1: weekdays at ten am Eastern on Applecarplay and Android Auto

176
00:08:27,840 --> 00:08:30,920
Speaker 1: with the Bloomberg Business App. Listen on demand wherever you

177
00:08:30,960 --> 00:08:33,920
Speaker 1: get your podcasts, or watch us live on YouTube.

178
00:08:34,280 --> 00:08:35,800
Speaker 5: Almost the last time you went to a movie at

179
00:08:35,800 --> 00:08:37,559
Speaker 5: a movie theater, oh, it was a.

180
00:08:37,480 --> 00:08:38,959
Speaker 3: Tough We were supposed to go to the other weekend

181
00:08:39,000 --> 00:08:42,720
Speaker 3: and see like Superman, but that didn't happen. I watch

182
00:08:42,760 --> 00:08:45,280
Speaker 3: a lot of them, like I stream them, like for example, Minecraft,

183
00:08:45,320 --> 00:08:46,959
Speaker 3: like I saw at home and then I didn't go

184
00:08:47,000 --> 00:08:49,320
Speaker 3: to the theater to see it. Right, that's what like

185
00:08:49,320 --> 00:08:50,360
Speaker 3: Warner Brothers is dealing.

186
00:08:50,600 --> 00:08:53,240
Speaker 5: Yeah, exactly right, So but I'm Warner Brothers Discovery they

187
00:08:53,240 --> 00:08:56,680
Speaker 5: put out results. I don't know. I mean, my expectations

188
00:08:56,720 --> 00:08:59,200
Speaker 5: are really low for this company, but they I thought

189
00:08:59,200 --> 00:09:01,480
Speaker 5: they were pretty decent stocks. Trading off a little bit here,

190
00:09:02,000 --> 00:09:04,040
Speaker 5: let's get the latest on what's happening at One Brother's

191
00:09:04,080 --> 00:09:06,440
Speaker 5: Discovery and even maybe a little bit on our friends

192
00:09:06,480 --> 00:09:09,920
Speaker 5: at Peloton. Jen Sherman's my buddy there. She's a person

193
00:09:09,960 --> 00:09:11,959
Speaker 5: I drink with. Of course, either wrong anah in us.

194
00:09:12,160 --> 00:09:13,640
Speaker 5: I'm not gonna do it with some dude. I mean,

195
00:09:13,679 --> 00:09:15,520
Speaker 5: you know, why would you do that. She's your friend

196
00:09:15,520 --> 00:09:18,920
Speaker 5: in your head exactly exactly where friends so githerrang and nothing.

197
00:09:18,960 --> 00:09:21,720
Speaker 5: She actually is the analyst on all this media stuff.

198
00:09:21,920 --> 00:09:26,160
Speaker 5: She's down there in our Princeton University sprawling campus. Hey, Gaeta,

199
00:09:26,160 --> 00:09:28,440
Speaker 5: talk to us about Warner Brothers Discovery, because there are

200
00:09:28,480 --> 00:09:30,319
Speaker 5: like a lot of traditional media comedies trying to make

201
00:09:30,320 --> 00:09:34,240
Speaker 5: that transition from the good old days of linear television,

202
00:09:34,400 --> 00:09:37,480
Speaker 5: cable television, all that kind of stuff to the streaming world.

203
00:09:37,600 --> 00:09:39,320
Speaker 5: What did you learn from Warner Brother's Discovery.

204
00:09:40,600 --> 00:09:42,960
Speaker 2: Yeah, so, Paul, what we really saw was, you know,

205
00:09:43,000 --> 00:09:45,640
Speaker 2: a continuation of the same. So the streaming business is

206
00:09:45,679 --> 00:09:48,439
Speaker 2: doing really well. The studio business is doing extremely well.

207
00:09:49,120 --> 00:09:52,600
Speaker 2: But TV Networks, which is really eighty percent off their ibadah,

208
00:09:53,040 --> 00:09:55,520
Speaker 2: is still struggling, and we saw a twenty five percent

209
00:09:55,840 --> 00:10:00,200
Speaker 2: slump in their TV Networks ibadah. So you know, that

210
00:10:00,240 --> 00:10:02,480
Speaker 2: continues to be a pain point. And while there was

211
00:10:02,520 --> 00:10:07,040
Speaker 2: initially some you know, obviously some excitement about the turnaround

212
00:10:07,120 --> 00:10:10,000
Speaker 2: and both the streaming and the studio businesses, the fact

213
00:10:10,000 --> 00:10:14,120
Speaker 2: that there is absolutely no respite inside for TV is

214
00:10:14,160 --> 00:10:15,840
Speaker 2: extremely distressing and that's.

215
00:10:15,679 --> 00:10:18,560
Speaker 3: Why their shares are down like seven percent. Okay, So

216
00:10:18,880 --> 00:10:21,040
Speaker 3: talk to me about the companies in the process of

217
00:10:21,080 --> 00:10:24,320
Speaker 3: splitting itself into two separate entities, right, So where do

218
00:10:24,400 --> 00:10:26,959
Speaker 3: we stand with that? What are the pros and cons

219
00:10:26,960 --> 00:10:27,680
Speaker 3: that go along with that?

220
00:10:28,760 --> 00:10:30,559
Speaker 2: Yeah, so this is you know, one of the best

221
00:10:30,559 --> 00:10:34,040
Speaker 2: ways for them, or at least you know, the fact

222
00:10:34,080 --> 00:10:36,920
Speaker 2: that they've kind of decided to do this really follows

223
00:10:36,920 --> 00:10:39,400
Speaker 2: a pattern in most of the media landscape where they're selling.

224
00:10:39,720 --> 00:10:42,199
Speaker 2: They're kind of separating the low growth assets from the

225
00:10:42,240 --> 00:10:44,200
Speaker 2: slightly higher growth assets. The low growth or the low

226
00:10:44,240 --> 00:10:48,880
Speaker 2: growth assets being the TV business. That for Warner Brothers,

227
00:10:48,920 --> 00:10:51,800
Speaker 2: that split will happen in the middle of next year,

228
00:10:52,840 --> 00:10:56,080
Speaker 2: and really the strategy here is to unlock shareholder value

229
00:10:56,080 --> 00:10:58,280
Speaker 2: because you know that, you know, they combine their Warner

230
00:10:58,280 --> 00:11:03,000
Speaker 2: Brothers business with a Discovery you know networks. Of course

231
00:11:03,040 --> 00:11:07,280
Speaker 2: that really hasn't gone anywhere. And so finally everybody in

232
00:11:07,320 --> 00:11:09,360
Speaker 2: the in the in the media world is doing this

233
00:11:09,440 --> 00:11:12,880
Speaker 2: where they're kind of separating out the secularly challenged TV networks.

234
00:11:13,320 --> 00:11:13,440
Speaker 6: Uh.

235
00:11:13,960 --> 00:11:16,160
Speaker 2: The only problem here is that we still really don't

236
00:11:16,200 --> 00:11:18,760
Speaker 2: have a very clear strategy. So they have to really

237
00:11:18,760 --> 00:11:20,719
Speaker 2: outline that, and I think that is part of the

238
00:11:20,760 --> 00:11:23,760
Speaker 2: reason why we're also kind of seeing this the decline

239
00:11:23,800 --> 00:11:24,640
Speaker 2: and shares this morning.

240
00:11:25,400 --> 00:11:28,920
Speaker 5: All Right, they had the studio had a good quarter here,

241
00:11:29,640 --> 00:11:33,120
Speaker 5: a couple in some some hits like Sinners, a Minecraft movie,

242
00:11:33,200 --> 00:11:35,720
Speaker 5: Final Destination, Bloodlines and things like that. Talk to us

243
00:11:35,720 --> 00:11:39,320
Speaker 5: about the studio and maybe it's kind of it's forward slate.

244
00:11:39,640 --> 00:11:40,760
Speaker 5: How does that look for the company?

245
00:11:41,600 --> 00:11:43,560
Speaker 2: The forward say it, Actually, it looks really good, Paul.

246
00:11:43,920 --> 00:11:48,320
Speaker 2: You know, they just had their major DC reboot with Superman. Uh,

247
00:11:48,520 --> 00:11:51,160
Speaker 2: and they're what they're really trying to do now going forward.

248
00:11:51,200 --> 00:11:53,600
Speaker 2: I mean, they didn't have a Superman movie for years.

249
00:11:53,640 --> 00:11:55,880
Speaker 2: Their DC strategy was in a mess. You know, it

250
00:11:55,920 --> 00:11:58,760
Speaker 2: was a mess. They had so many movies out there,

251
00:11:58,800 --> 00:12:02,000
Speaker 2: it was all confusing lines. But I think finally they've

252
00:12:02,080 --> 00:12:04,320
Speaker 2: kind of they're going to write that ship. So they've

253
00:12:04,320 --> 00:12:07,640
Speaker 2: committed to a pretty strong slate of about twelve to

254
00:12:07,679 --> 00:12:12,080
Speaker 2: fourteen movies going forward. The big thing for them is

255
00:12:12,120 --> 00:12:15,440
Speaker 2: to really get Studio EBITDA to about three billion dollars,

256
00:12:15,440 --> 00:12:17,080
Speaker 2: and they seem to be well on their way. I mean,

257
00:12:17,160 --> 00:12:20,840
Speaker 2: last year was a complete mess. This year definitely much

258
00:12:20,920 --> 00:12:23,000
Speaker 2: much better. They're actually if you just look at box

259
00:12:23,000 --> 00:12:26,560
Speaker 2: office performance overall, they already have about a twenty five

260
00:12:26,640 --> 00:12:29,040
Speaker 2: twenty six percent share of the domestic box office, so

261
00:12:29,080 --> 00:12:32,000
Speaker 2: they're only very slightly behind Disney. So they're definitely doing

262
00:12:32,000 --> 00:12:34,880
Speaker 2: well and their strategy is working. They have a pretty

263
00:12:34,880 --> 00:12:36,000
Speaker 2: good content pipeline.

264
00:12:36,080 --> 00:12:38,640
Speaker 3: All right, let's switch over at Peloton. How is this

265
00:12:38,720 --> 00:12:41,880
Speaker 3: company doing? I mean, is there subscribers? Are they continuing

266
00:12:41,880 --> 00:12:44,840
Speaker 3: to come in? Are people still using this equipment as

267
00:12:44,920 --> 00:12:46,200
Speaker 3: much as they used to?

268
00:12:47,720 --> 00:12:51,400
Speaker 2: So for Peloton, really and the story has not been

269
00:12:51,440 --> 00:12:54,680
Speaker 2: so much on subscribers, unfortunately. It has really been more

270
00:12:54,800 --> 00:12:59,080
Speaker 2: about trimming the fat literally at the company and kind

271
00:12:59,120 --> 00:13:01,400
Speaker 2: of getting profits into full focus. And if you just

272
00:13:01,440 --> 00:13:03,960
Speaker 2: saw this quarter's results and what they reported for the

273
00:13:03,960 --> 00:13:06,360
Speaker 2: full year. For fiscal twenty twenty five, I mean, the

274
00:13:07,520 --> 00:13:10,000
Speaker 2: progress that they've made in terms of profitability has been

275
00:13:10,040 --> 00:13:14,640
Speaker 2: absolutely outstanding. So they reported adjusted IBADAH that came in

276
00:13:14,679 --> 00:13:19,240
Speaker 2: about nineteen twenty percent higher than guidance and consensus their

277
00:13:19,840 --> 00:13:23,200
Speaker 2: forward guidance, So fiscal twenty twenty six suggested EBITDA guidance

278
00:13:23,280 --> 00:13:26,200
Speaker 2: is also was also way above consensus. So the way

279
00:13:26,200 --> 00:13:29,640
Speaker 2: that they're kind of optimizing their operating expenses has been

280
00:13:29,679 --> 00:13:33,880
Speaker 2: absolutely stellar. You know, just everything in terms of workforce reduction,

281
00:13:33,960 --> 00:13:37,600
Speaker 2: in terms of inventory management, you know, op X costs,

282
00:13:37,640 --> 00:13:41,800
Speaker 2: marketing expenses, everything has been absolutely top notch. The only

283
00:13:41,880 --> 00:13:45,600
Speaker 2: problem for them is reintegrating demand. And that's where you know,

284
00:13:45,640 --> 00:13:48,280
Speaker 2: we're kind of really kind of seeing this disconnect because

285
00:13:48,360 --> 00:13:52,040
Speaker 2: the financial metrics are really good, but the subscriber metrics,

286
00:13:52,120 --> 00:13:53,320
Speaker 2: unfortunately are not.

287
00:13:54,120 --> 00:13:57,079
Speaker 5: Is there a credible plan there to reignite growth there?

288
00:13:58,679 --> 00:14:01,120
Speaker 5: I just kind of it feels like, you know, everybody

289
00:14:01,160 --> 00:14:05,240
Speaker 5: who's got one's got one. How did they think talk

290
00:14:05,240 --> 00:14:06,280
Speaker 5: about that part of the story.

291
00:14:07,080 --> 00:14:09,760
Speaker 2: Yeah, so it's really going to be a little bit hard.

292
00:14:10,120 --> 00:14:11,719
Speaker 2: I mean, yeah, on the margin, I think they can

293
00:14:11,760 --> 00:14:14,160
Speaker 2: do some things to kind of reignite a little bit

294
00:14:14,160 --> 00:14:16,920
Speaker 2: of the hardware sales, but in terms of a sustainable

295
00:14:17,000 --> 00:14:20,600
Speaker 2: go forward strategy that is really still pretty unclear. Paul, So,

296
00:14:20,640 --> 00:14:22,680
Speaker 2: I think right now, what they're really trying to do

297
00:14:22,800 --> 00:14:26,120
Speaker 2: is again really get you know, more costs out of

298
00:14:26,160 --> 00:14:30,600
Speaker 2: the system, maybe increase subscription prices a little bit, so

299
00:14:30,760 --> 00:14:33,200
Speaker 2: kind of pad that top line a little bit. But

300
00:14:33,240 --> 00:14:36,080
Speaker 2: in terms of you know, the overall subscription growth story,

301
00:14:36,960 --> 00:14:38,960
Speaker 2: I'm not so sure that's really going to be a

302
00:14:39,040 --> 00:14:41,760
Speaker 2: volume story. I think it's it's going to you know,

303
00:14:42,160 --> 00:14:45,400
Speaker 2: focus more on kind of rates and price and improving

304
00:14:45,440 --> 00:14:46,920
Speaker 2: pricing and either how much.

305
00:14:46,760 --> 00:14:49,280
Speaker 3: Of that, you know, cutting costs includes cutting jobs.

306
00:14:50,320 --> 00:14:53,400
Speaker 2: Yeah, they did actually you know, announce a six percent

307
00:14:53,560 --> 00:14:56,200
Speaker 2: workforce reduction as well, so a lot of it is

308
00:14:56,240 --> 00:14:57,680
Speaker 2: going to come down to cutting jobs.

309
00:14:58,040 --> 00:15:01,240
Speaker 5: All right, Just one quick thing on Warner Brothers Discovery.

310
00:15:01,280 --> 00:15:04,440
Speaker 5: What's the timing of this separation it's.

311
00:15:04,280 --> 00:15:07,640
Speaker 2: Going to So they announced the formal plan in June.

312
00:15:07,800 --> 00:15:10,760
Speaker 2: It's going to happen by Midge twenty twenty six, so

313
00:15:10,800 --> 00:15:11,800
Speaker 2: by middle of next year.

314
00:15:12,200 --> 00:15:14,040
Speaker 5: Okay, all right, we'll keep an eye on that. Gith

315
00:15:14,040 --> 00:15:16,040
Speaker 5: Throng and at and she covers all the media stuff

316
00:15:17,000 --> 00:15:20,120
Speaker 5: for Bloomberg intelligence down there for them to display.

317
00:15:20,120 --> 00:15:21,440
Speaker 3: I mean, you see Comcasts do it right.

318
00:15:21,560 --> 00:15:25,120
Speaker 5: Yeah, I think it is simply because you hope that

319
00:15:25,120 --> 00:15:28,880
Speaker 5: the two parts have more total value than they do together,

320
00:15:29,320 --> 00:15:32,800
Speaker 5: and so you're concerned that the high growth business is

321
00:15:32,840 --> 00:15:36,640
Speaker 5: being pulled down by the slower growth cable networks. So

322
00:15:36,680 --> 00:15:39,320
Speaker 5: you split them out and see how far this, you know,

323
00:15:39,440 --> 00:15:42,760
Speaker 5: the streaming business in the studio can fly, I guess

324
00:15:42,880 --> 00:15:44,560
Speaker 5: is kind of the thought there. So we see it

325
00:15:44,560 --> 00:15:47,720
Speaker 5: all the time and lots of different industries, and there

326
00:15:47,800 --> 00:15:49,840
Speaker 5: was a time, you know, when all these assets made

327
00:15:50,280 --> 00:15:53,360
Speaker 5: sense to be together. But the fortunes, the economic fortunes

328
00:15:53,360 --> 00:15:56,200
Speaker 5: of the cable network and broadcast network business have been

329
00:15:56,240 --> 00:16:01,480
Speaker 5: permanently damaged, and it gets worse every year. So you know,

330
00:16:01,520 --> 00:16:03,560
Speaker 5: you just got to cut those out and see how

331
00:16:03,560 --> 00:16:06,520
Speaker 5: they trade on a standalone basis. Maybe ultimately they get acquired,

332
00:16:07,000 --> 00:16:09,880
Speaker 5: or maybe some of these networks maybe get together the

333
00:16:09,920 --> 00:16:12,880
Speaker 5: Comcast stuff. Maybe we'll get together with the Warner brother

334
00:16:12,920 --> 00:16:15,120
Speaker 5: stuff and just become bigger and get some cross energy.

335
00:16:15,160 --> 00:16:17,240
Speaker 5: So we'll see how that plays out. But we're seeing

336
00:16:17,280 --> 00:16:18,480
Speaker 5: that across the media space.

337
00:16:18,520 --> 00:16:20,000
Speaker 6: Here.

338
00:16:20,640 --> 00:16:24,320
Speaker 1: You're listening to the Bloomberg Intelligence podcast. Catch us live

339
00:16:24,400 --> 00:16:27,800
Speaker 1: weekdays at ten am Eastern on Applecarclay, and Android Auto

340
00:16:27,920 --> 00:16:30,960
Speaker 1: with the Bloomberg Business app. Listen on demand wherever you

341
00:16:31,000 --> 00:16:34,000
Speaker 1: get your podcasts, or watch us live on YouTube.

342
00:16:34,480 --> 00:16:39,320
Speaker 5: Intel coming into the crosshairs of President Trump day, particularly

343
00:16:39,320 --> 00:16:41,840
Speaker 5: the CEO saying he's got to go. I mean, I

344
00:16:41,880 --> 00:16:46,000
Speaker 5: have no idea where that came from. I'm guessing Man

345
00:16:46,080 --> 00:16:48,280
Speaker 5: Deep Sing is read up on this. If nothing else,

346
00:16:48,360 --> 00:16:52,200
Speaker 5: Man Deep seeing senior tech analyst from Bloomberg Intelligence, President

347
00:16:52,240 --> 00:16:55,520
Speaker 5: Trump calling for this CEO of Intel to quit not

348
00:16:55,760 --> 00:16:58,280
Speaker 5: He says he's conflicted. Can you give us the backstory

349
00:16:58,320 --> 00:16:59,640
Speaker 5: what's going on here? As far as you know?

350
00:17:00,480 --> 00:17:04,080
Speaker 6: I mean, most likely it has to do with the

351
00:17:04,119 --> 00:17:10,320
Speaker 6: minority investments that the Intel CEO has in companies within China,

352
00:17:10,560 --> 00:17:15,080
Speaker 6: and they may have some ties to the Chinese government

353
00:17:15,119 --> 00:17:17,600
Speaker 6: in some way. And look, he used to be a VC,

354
00:17:17,960 --> 00:17:23,359
Speaker 6: so this guy has had multiple roles. He used to

355
00:17:23,359 --> 00:17:26,200
Speaker 6: be the CEO of Cadence, then he was a VC

356
00:17:27,119 --> 00:17:31,240
Speaker 6: with you know, multiple investments in startups across the globe.

357
00:17:31,359 --> 00:17:36,359
Speaker 6: So I'm guessing the board Intel board before they appointed

358
00:17:36,720 --> 00:17:39,399
Speaker 6: him as the CEO, did their due diligence in terms

359
00:17:39,440 --> 00:17:43,080
Speaker 6: of looking at all these aspects, and to my mind,

360
00:17:43,960 --> 00:17:47,719
Speaker 6: I mean, it obviously is a surprise that, you know,

361
00:17:49,040 --> 00:17:51,760
Speaker 6: I mean, his credentials are being questioned here given the

362
00:17:51,840 --> 00:17:53,560
Speaker 6: reputation he has in the valley.

363
00:17:54,520 --> 00:18:00,720
Speaker 7: Is the American citizen I'm not sure, probably, but I mean,

364
00:18:01,040 --> 00:18:03,320
Speaker 7: those are the type of things he would expect the

365
00:18:03,359 --> 00:18:05,199
Speaker 7: board to do their due diligence on.

366
00:18:05,280 --> 00:18:09,560
Speaker 6: For a company like Intel, which has had multiple CEOs

367
00:18:09,600 --> 00:18:13,479
Speaker 6: and clearly is looking for a big turnaround, A lot

368
00:18:13,560 --> 00:18:16,760
Speaker 6: of people felt this guy had the credentials, you know,

369
00:18:16,840 --> 00:18:19,399
Speaker 6: in terms of having the experience to turn around a

370
00:18:19,400 --> 00:18:23,320
Speaker 6: big ship like Intel. And I mean, so far, it's

371
00:18:23,320 --> 00:18:25,520
Speaker 6: too early to call out how good of a job

372
00:18:25,640 --> 00:18:29,359
Speaker 6: he was doing. Still early days with his strategy, but

373
00:18:29,560 --> 00:18:34,320
Speaker 6: clearly he has plans to keep the foundry business and

374
00:18:34,440 --> 00:18:38,520
Speaker 6: turn around the core chip design business, and he has

375
00:18:39,080 --> 00:18:42,760
Speaker 6: raised a lot of cash. So I would say still

376
00:18:42,800 --> 00:18:47,159
Speaker 6: early days with his strategy. But this clearly puts, you know,

377
00:18:47,280 --> 00:18:50,160
Speaker 6: a wrench in terms of his strategy.

378
00:18:50,320 --> 00:18:54,320
Speaker 5: Just as per Wiki Wikipedia, it says that he is

379
00:18:54,359 --> 00:18:58,400
Speaker 5: a Malaysian born American business executive. So that's all I got.

380
00:18:58,880 --> 00:19:01,679
Speaker 3: Well, something you brought up that they probably you know,

381
00:19:01,760 --> 00:19:04,840
Speaker 3: people already knew about this. You know, this is no secret.

382
00:19:05,600 --> 00:19:08,439
Speaker 3: My question is why now? Why bring this up?

383
00:19:08,440 --> 00:19:08,600
Speaker 2: Now?

384
00:19:08,640 --> 00:19:11,000
Speaker 3: Why the timing now? And the company has been struggling, right,

385
00:19:11,040 --> 00:19:13,600
Speaker 3: it's chairs now or down what they're down three percent

386
00:19:13,640 --> 00:19:16,040
Speaker 3: this morning? But why do you think this has taking

387
00:19:16,040 --> 00:19:16,560
Speaker 3: place now?

388
00:19:17,240 --> 00:19:20,919
Speaker 6: I think it's because Senator Tom Cotton, he wrote a

389
00:19:21,000 --> 00:19:25,040
Speaker 6: letter to the Intel board. They obviously found out some

390
00:19:25,200 --> 00:19:30,000
Speaker 6: things that he the Senator highlighted, you know, the links

391
00:19:30,040 --> 00:19:34,640
Speaker 6: to some of the Chinese companies, small companies that had

392
00:19:34,680 --> 00:19:39,200
Speaker 6: ties to the Chinese government. And I think the board

393
00:19:39,280 --> 00:19:42,320
Speaker 6: probably has to come up with an answer in terms

394
00:19:42,320 --> 00:19:44,920
Speaker 6: of the you know, the concerns that were raised by

395
00:19:44,960 --> 00:19:45,520
Speaker 6: a senator.

396
00:19:46,400 --> 00:19:49,720
Speaker 5: Has the company responded at all to the senator or

397
00:19:49,760 --> 00:19:50,119
Speaker 5: the president?

398
00:19:50,200 --> 00:19:53,840
Speaker 6: I mean they have in terms of the initial response,

399
00:19:54,080 --> 00:19:58,840
Speaker 6: But to the best of my knowledge, I think the

400
00:19:58,840 --> 00:20:03,359
Speaker 6: board clearly is defending uh, you know, the credentials of

401
00:20:04,040 --> 00:20:09,120
Speaker 6: their CEO and uh there's nothing here that would put

402
00:20:09,160 --> 00:20:13,400
Speaker 6: a question mark around the future of libbutan in terms

403
00:20:13,440 --> 00:20:15,120
Speaker 6: of running Intel at least for now.

404
00:20:15,000 --> 00:20:15,720
Speaker 2: Well, that's what I say.

405
00:20:15,720 --> 00:20:17,600
Speaker 3: Do you think he would would step down? How long

406
00:20:17,600 --> 00:20:18,640
Speaker 3: has he been in a position?

407
00:20:18,720 --> 00:20:20,200
Speaker 6: Not few months?

408
00:20:20,280 --> 00:20:21,280
Speaker 2: Yeah, exactly? Yea.

409
00:20:21,720 --> 00:20:24,359
Speaker 5: So how is the Intel call here? I mean the

410
00:20:24,400 --> 00:20:30,840
Speaker 5: stock obviously underperforming, under underperforming pretty dramatically here. It's you know,

411
00:20:31,000 --> 00:20:34,080
Speaker 5: flat year to date, but you know, relative to Tech

412
00:20:34,119 --> 00:20:35,359
Speaker 5: that's just losing ground.

413
00:20:35,440 --> 00:20:39,760
Speaker 6: Germanic they are. And this brings back, you know, some

414
00:20:39,840 --> 00:20:43,040
Speaker 6: of the discussions we were having a few months back

415
00:20:43,119 --> 00:20:46,760
Speaker 6: before Libbutan was appointed as a CEO that Intel may

416
00:20:46,800 --> 00:20:51,560
Speaker 6: be broken down, Qualcom may be looking to buy parts

417
00:20:51,560 --> 00:20:54,639
Speaker 6: of Intel, and then the foundry business would be separated.

418
00:20:55,280 --> 00:20:58,520
Speaker 6: I feel if for some reason this CEO has to

419
00:20:58,640 --> 00:21:01,080
Speaker 6: step down and you know, so someone else is appointed,

420
00:21:01,560 --> 00:21:05,199
Speaker 6: then it brings all those discussions back into play, because

421
00:21:05,520 --> 00:21:09,160
Speaker 6: so far, what lib Bhutan had maintained was he wants

422
00:21:09,200 --> 00:21:12,159
Speaker 6: to keep the foundry business. He wants to turn around

423
00:21:12,200 --> 00:21:16,280
Speaker 6: through a strategy that involved keeping the chip design and

424
00:21:16,320 --> 00:21:19,560
Speaker 6: the foundry business together. But if that wasn't to be

425
00:21:19,640 --> 00:21:22,520
Speaker 6: the case, and if there's somebody new, then I would

426
00:21:22,560 --> 00:21:26,080
Speaker 6: say that whole aspect around breaking up Intel comes back

427
00:21:26,080 --> 00:21:26,600
Speaker 6: into play.

428
00:21:26,800 --> 00:21:27,080
Speaker 7: All right.

429
00:21:27,240 --> 00:21:30,480
Speaker 5: Stock is down three percent today, so it is feeling

430
00:21:30,520 --> 00:21:32,439
Speaker 5: the impact of that many i've seen. Thank you so

431
00:21:32,480 --> 00:21:35,360
Speaker 5: much for joining us, Senior techanost for Bloomberg Intelligence. Joining

432
00:21:35,400 --> 00:21:38,480
Speaker 5: us here in our studio again. The headline Trump urges

433
00:21:38,600 --> 00:21:43,719
Speaker 5: quote conflicted Intel CEO ten to resign immediately.

434
00:21:44,640 --> 00:21:49,359
Speaker 1: This is the Bloomberg Intelligence Podcast, available on Apple, Spotify,

435
00:21:49,560 --> 00:21:53,480
Speaker 1: and anywhere else you get your podcasts. Listen live each weekday,

436
00:21:53,720 --> 00:21:57,000
Speaker 1: ten am to noon Eastern on Bloomberg dot com, the

437
00:21:57,080 --> 00:22:00,960
Speaker 1: iHeartRadio app, tune In, and the Bloomberg Business app. You

438
00:22:00,960 --> 00:22:04,280
Speaker 1: can also watch us live every weekday on YouTube and

439
00:22:04,480 --> 00:22:06,440
Speaker 1: always on the Bloomberg terminal